...
首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation.
【24h】

Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation.

机译:患有遗传性乳腺癌(HB(O)C)或经证实的BRCA1和BRCA2种系突变的女性,进行预防性乳房切除术后立即进行乳房重建的临床经验。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: Women with a proven BRCA1 or BRCA2 germ-line mutation or with a 50% risk of carrying the mutation, have an increased risk of breast cancer. Regular surveillance, chemoprevention or prophylactic mastectomy (PM) are options to detect breast cancer at an early stage or to reduce the risk. We describe the management of women who have opted for PM, the postoperative complications of PM, especially in combination with immediate breast reconstruction (IBR), and the oncological follow-up.METHODS: The medical records of all women who underwent a PM from December 1993 to December 1999 have been reviewed with respect to management, patient characteristics, complications and oncological follow-up.RESULTS: During the study period 112 women with a median age of 38.8 years opted for a PM: 76 were germline mutation carriers. After PM, 79 women without breast or ovarian cancer in their medical history, were free of disease after 2.5 years (median). Before PM, 29 women had been treated for breast cancer, 3.9 years (median) previously; 5 of these women had developed metastatic disease by the last consultation. Before PM, 2 patients had been treated for DCIS and 2 patients for ovarian cancer. Four DCIS were found; none of these women had evidence of disease 4.0 years (median) after PM. In 59 women laparoscopic prophylactic bilateral oophorectomy (PBO) was performed; 36 simultaneously with PM and 23 separately. A total of 103 women (92%) opted for IBR. After PM, the complication rate for IBR was 21%: 11% within 6 weeks and 10% at long-term follow-up (median 3.5) after PM, including the removal of 10 prostheses.CONCLUSIONS: Women with an increased risk of breast cancer due to a genetic predisposition should be adequately informed about the different treatment options in the setting of a multidisciplinary approach. PM can simultaneously be combined with PBO and IBR. IBR can facilitate the decision to undergo a PM. PM followed by IBR has an acceptable complication rate.
机译:目的:具有可靠的BRCA1或BRCA2种系突变或携带该突变的风险为50%的妇女,患乳腺癌的风险增加。定期监视,化学预防或预防性乳房切除术(PM)是早期发现乳腺癌或降低风险的选择。我们描述了选择PM的妇女的管理,PM的术后并发症,特别是与立即乳房重建(IBR)结合以及肿瘤学随访。方法:从12月开始接受PM的所有妇女的病历从1993年至1999年12月对治疗,患者特征,并发症和肿瘤学随访进行了回顾。结果:在研究期间,有112名中位年龄为38.8岁的女性选择了PM:76名是种系突变携带者。 PM后,有79名在其病史中没有乳腺癌或卵巢癌的妇女在2.5年后没有疾病(中位数)。在PM之前,有29名妇女接受过乳腺癌治疗,之前为3.9年(中值);这些妇女中有5名在上次咨询时已发展成转移性疾病。在PM之前,有2例患者接受了DCIS治疗,2例患者接受了卵巢癌治疗。发现了四个DCIS;这些女性中没有一个在PM后4.0年(中位数)有疾病迹象。在59名女性中,进行了腹腔镜预防性双侧卵巢切除术(PBO);与PM同时显示36和23。共有103名妇女(占92%)选择了IBR。 PM后,IBR的并发症发生率为21%:6周内为11%,长期随访(中位3.5)为10%,其中包括去除10个假体。结论:女性患乳腺癌的风险增加对于因遗传易感性引起的癌症,应在多学科方法中充分了解不同的治疗方案。 PM可同时与PBO和IBR结合使用。 IBR可以促进进行PM的决定。继之以IBR的PM的并发症发生率可以接受。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号